James Brett Case

Active 2015–2025

80
Papers
19,890
Citations
51
h-index
78
i10-index

Citations

Citations per year for James Brett Case2001: 1 citations2005: 1 citations2015: 1 citations2016: 3 citations2017: 3 citations2018: 6 citations2019: 46 citations2020: 1,642 citations2021: 2,995 citations2022: 2,175 citations2023: 884 citations2024: 1,084 citations2025: 386 citations2026: 6 citations2002–2004: no citations, so these years are not shown2006–2014: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,856 citing papers, 28.9% of this breakdownChina: 1,143 citing papers, 11.6% of this breakdownUnited Kingdom: 606 citing papers, 6.1% of this breakdownGermany: 409 citing papers, 4.1% of this breakdownIndia: 356 citing papers, 3.6% of this breakdownFrance: 312 citing papers, 3.2% of this breakdownCanada: 310 citing papers, 3.1% of this breakdownItaly: 303 citing papers, 3.1% of this breakdownAustralia: 255 citing papers, 2.6% of this breakdownJapan: 244 citing papers, 2.5% of this breakdownSwitzerland: 232 citing papers, 2.3% of this breakdownNetherlands: 172 citing papers, 1.7% of this breakdown
0%28.9%Other 27.2%

Fields

  • Medicine81.2%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology5%
  • Computer Science1.6%
  • Agricultural and Biological Sciences0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2.5%

Topics

  • SARS-CoV-2 and COVID-19 Research24.6%
  • COVID-19 Clinical Research Studies14%
  • SARS-CoV-2 detection and testing3.8%
  • Animal Virus Infections Studies3.7%
  • Viral gastroenteritis research and epidemiology3.6%
  • Long-Term Effects of COVID-193.5%
  • Other46.8%

Coauthors

All papers

Open in search
  1. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 2,160

  2. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 890

  3. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

    Authors: , , , , , , , , , , , , , , - Science 2020 cited by 734

  4. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy R. Henry, Karl Čiuoderis, Kelsey R. Florek, Mit Patel, Abby Odle, Lok-Yin Roy Wong, Allen Bateman, Zhongde Wang, Venkata Viswanadh Edara, Zhenlu Chong, John Franks, Trushar Jeevan, Thomas Fabrizio, Jennifer DeBeauchamp, Lisa Kercher, Patrick Seiler, Ana S. Gonzalez‐Reiche, Emilia Mia Sordillo, Lauren A. Chang, Harm van Bakel, Viviana Simon, Bremy Alburquerque, Hala Alshammary, Angela A. Amoako, Sadaf Aslam, Radhika Banu, Christian Cognigni, Marlene Espinoza‐Moraga, Keith Farrugia, Adriana van de Guchte, Zain Khalil, Manon Laporte, Ignacio Mena, Alberto Paniz‐Mondolfi, J. Polanco, Aria Rooker, Levy A. Sominsky, Daniel C. Douek, Nancy J. Sullivan, Larissa B. Thackray, Hiroshi Ueki, Seiya Yamayoshi, Masaki Imai, Stanley Perlman, Richard J. Webby, Robert A. Seder, Mehul S. Suthar, Adolfo García‐Sastre, Michael Schotsaert, Tadaki Suzuki, Adrianus C. M. Boon, Michael Diamond, Yoshihiro Kawaoka - Nature 2022 cited by 700

  5. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Diamond - Cell 2020 cited by 635

  6. Potently neutralizing and protective human antibodies against SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicole L. Kallewaard, Broc T. McCune, Shamus P. Keeler, Michael J. Holtzman, Dan H. Barouch, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe - Nature 2020 cited by 1,201

  7. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William T. Hu, F. Eun‐Hyung Lee, Igñacio Sanz - Nature Immunology 2020 cited by 795

  8. Neutralization, effector function and immune imprinting of Omicron variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julia Noack, Alex Chen, Florian A. Lempp, Joel Quispe, Lauriane Kergoat, Florence Larrous, Elisabetta Cameroni, Bradley Whitener, Olivier Giannini, Pietro E. Cippà, Alessandro Ceschi, Paolo Ferrari, Alessandra Franzetti-Pellanda, Maira Biggiogero, Christian Garzoni, Stephanie Zappi, Luca Bernasconi, Minjeong Kim, Laura E. Rosen, Gretja Schnell, Nadine Czudnochowski, Fabio Benigni, Nicholas Franko, Jennifer K. Logue, Courtney Yoshiyama, Cameron Stewart, Helen Y. Chu, Hervé Bourhy, Michael Schmid, Lisa A. Purcell, Gyorgy Snell, Antonio Lanzavecchia, Michael Diamond, Davide Corti, David Veesler - Nature 2023 cited by 181

  9. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pei‐Yong Shi, Michael Diamond - Nature Medicine 2021 cited by 1,015

  10. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2017 cited by 1,634

  11. The antigenic anatomy of SARS-CoV-2 receptor binding domain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert H. Levin, Tao Dong, Andrew J. Pollard, Julian C. Knight, Paul Klenerman, Nigel Temperton, David R. Hall, Mark A. Williams, Neil G. Paterson, F.K.R. Bertram, C. Alistair Siebert, Daniel K. Clare, Andrew Howe, Julika Radecke, Yun Song, Alain Townsend, Kuan-Ying A. Huang, Elizabeth E. Fry, Juthathip Mongkolsapaya, Michael Diamond, Jingshan Ren, David I. Stuart, Gavin Screaton - Cell 2021 cited by 440

  12. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

    Authors: , , , , , , , , , , , , , , , , - mBio 2018 cited by 1,514

  13. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

    Authors: , , , , , , , , , , , , , - Nature 2020 cited by 167

  14. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Culap, Fabio Benigni, Rana Abdelnabi, Caroline S. Foo, Michael Schmid, Elisabetta Cameroni, Agostino Riva, Arianna Gabrieli, Massimo Galli, Matteo Samuele Pizzuto, Johan Neyts, Michael Diamond, Herbert W. Virgin, Gyorgy Snell, Davide Corti, Katja Fink, David Veesler - Science 2020 cited by 630

  15. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesse D. Bloom, James E. Crowe - Nature Microbiology 2021 cited by 330

  16. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ousman Jobe, Vincent Dussupt, Sebastian Molnar, Ursula Tran, Chandrika B. Kannadka, Sandrine Soman, Caitlin Kuklis, Michelle Zemil, Htet Khanh, Weimin Wu, Matthew Cole, Debra K. Duso, Larry Kummer, Tricia J. Lang, Shania E. Muncil, Jeffrey R. Currier, Shelly J. Krebs, Victoria R. Polonis, Saravanan Rajan, Patrick M. McTamney, Mark T. Esser, William W. Reiley, Morgane Rolland, Natalia de Val, Michael Diamond, Gregory D. Gromowski, Gary R. Matyas, Mangala Rao, Nelson L. Michael, Kayvon Modjarrad - Cell Reports 2021 cited by 186

  17. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2021 cited by 392

  18. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manoj S. Nair, Vincent Dussupt, Sharon P. Daye, Xiankun Zeng, Erica K. Barkei, Hilary Staples, Kendra J. Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin‐Proulx, Nicos Karasavva, Victoria R. Polonis, Linda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. Peel, Nelson L. Michael, Diane L. Bolton, Kayvon Modjarrad - Science Translational Medicine 2022 cited by 145

  19. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2024 cited by 81

  20. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2024 cited by 79

  21. Growth, detection, quantification, and inactivation of SARS-CoV-2

    Authors: , , , , - Virology 2020 cited by 295

  22. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 154

  23. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2020 cited by 579

  24. Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natasha I. Edman, George Ueda, Cameron M. Chow, Max Johnson, Amin Addetia, Mary-Jane Navarro, Nuttada Panpradist, Michael Gale, Benjamin Freedman, Jesse D. Bloom, Hannele Ruohola‐Baker, Sean P. J. Whelan, Lance Stewart, Michael Diamond, David Veesler, Michael C. Jewett, David Baker - Science Translational Medicine 2022 cited by 118